Presentation MISTRAL: Prehospital Abciximab in STEMI Presenter: Patrick Ohlmann February 09, 2012 REGISTER for free or LOG IN to view this content CAD Pharma ACS/AMI Factoid Up Next Presentation Cost Effectiveness of TAVR vs. Standard Care in Inoperable Patients with Severe Aortic Stenosis Presenter: M. R. Reynolds February 09, 2012 More slides + Presentation MISTRAL: Abciximab Prehospitalario contra STEMI Presenter: Patrick Ohlmann February 09, 2012 Presentation Creación de Shunt AV Femoral Percutáneao para la EPOC en Fase Avanzada Presenter: S. Bertog February 12, 2012 We Recommend
Presentation Cost Effectiveness of TAVR vs. Standard Care in Inoperable Patients with Severe Aortic Stenosis Presenter: M. R. Reynolds February 09, 2012
Presentation MISTRAL: Abciximab Prehospitalario contra STEMI Presenter: Patrick Ohlmann February 09, 2012
Presentation Creación de Shunt AV Femoral Percutáneao para la EPOC en Fase Avanzada Presenter: S. Bertog February 12, 2012